Tenaya Therapeutics, Inc.
TNYANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $84.64M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.36$1.96
- Volume (live)
- -
- Avg. volume (3M)
- 3.71M
Tenaya Therapeutics (TNYA) Stock Price & Financial Analysis
Tenaya Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.38 - $0.40 |
|---|---|
| 52-Week High | $1.96 |
| 52-Week Low | $0.36 |
| Open | $0.39 |
| Volume (last close) | 1.70M |
| Average Volume (3M) | 3.71M |
| Revenue (TTM) | 1.33M |
|---|---|
| Net Income (TTM) | -103.11M |
| Free Cash Flow (TTM) | -52.59M |
| EPS (TTM) | −$0.53 |
| Profit Margin | -7723.97% |
| Operating Margin | -6192.88% |
| Return on Equity (ROE) | -148.56% |
| Debt to Equity | 0.06 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 84.64M |
|---|---|
| Shares Outstanding | 217.57M |
| Price to Sales (P/S) | 63.40 |
| Price to Book (P/B) | 1.22 |
| EV/EBITDA | -0.14 |
| 50-Day MA | $0.63 |
|---|---|
| 200-Day MA | $0.73 |
| 1-Year Change | −76.90% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Tenaya Therapeutics at a Glance
As of the Oct 23, 2026 close, Tenaya Therapeutics (TNYA) has a market capitalization of $84.64M. The stock trades at 63.4× sales. Over the trailing twelve months it lost $103.11M on revenue of $1.33M and burned $52.59M of free cash flow.
As of its latest reported balance sheet, it holds $78.08M in cash and securities against $3.95M of debt, a net cash position of $74.14M.
Tenaya Therapeutics does not currently pay a dividend.
The share price is down 76.9% over the past year. At $0.39 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.36 to $1.96, below its 200-day moving average of $0.72.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $13.00, 3241.9% above the Oct 23, 2026 close.
Frequently Asked Questions About Tenaya Therapeutics
What is the current stock price for TNYA?
As of the Oct 23, 2026 close, TNYA stock trades at $0.39. The 52-week range is $0.36–$1.96, with a day range of $0.38–$0.40.
What is the P/E ratio for TNYA?
The P/E ratio (Price-to-Earnings) for TNYA is shown in the Key Statistics section. This valuation metric helps compare Tenaya Therapeutics, Inc. to industry peers.
Does TNYA pay dividends?
Tenaya Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TNYA?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for TNYA is Buy. The average 12-month price target is $13.00, a 3241.9% upside from the Oct 23, 2026 close of $0.39.
What is the market cap of TNYA?
As of the Oct 23, 2026 close, Tenaya Therapeutics's market capitalization is $84.6M, classifying it as a micro-cap company. Tenaya Therapeutics operates in the Healthcare sector within the Biotechnology industry.